1. Home
  2. GLAD vs DNA Comparison

GLAD vs DNA Comparison

Compare GLAD & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gladstone Capital Corporation

GLAD

Gladstone Capital Corporation

HOLD

Current Price

$21.22

Market Cap

482.1M

Sector

Finance

ML Signal

HOLD

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

HOLD

Current Price

$9.16

Market Cap

562.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLAD
DNA
Founded
2001
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
482.1M
562.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GLAD
DNA
Price
$21.22
$9.16
Analyst Decision
Strong Buy
Strong Sell
Analyst Count
3
1
Target Price
$22.33
$9.00
AVG Volume (30 Days)
206.8K
1.2M
Earning Date
11-17-2025
11-06-2025
Dividend Yield
9.34%
N/A
EPS Growth
N/A
N/A
EPS
2.55
N/A
Revenue
$89,122,000.00
$180,606,000.00
Revenue This Year
$13.04
N/A
Revenue Next Year
$9.55
$7.28
P/E Ratio
$8.33
N/A
Revenue Growth
N/A
N/A
52 Week Low
$18.76
$5.00
52 Week High
$30.43
$17.58

Technical Indicators

Market Signals
Indicator
GLAD
DNA
Relative Strength Index (RSI) 63.19 45.00
Support Level $20.70 $8.56
Resistance Level $21.35 $9.38
Average True Range (ATR) 0.44 0.55
MACD 0.16 0.26
Stochastic Oscillator 90.96 69.31

Price Performance

Historical Comparison
GLAD
DNA

About GLAD Gladstone Capital Corporation

Gladstone Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its investment objectives are to, achieve and grow current income by investing in debt securities of established businesses that would provide stable earnings and cash flow to pay expenses, make principal and interest payments on its outstanding indebtedness, and make distributions to stockholders that grow over time; and provide its stockholders with long-term capital appreciation in the value of its assets by investing in equity securities of established businesses that can grow over time to permit it to sell its equity investments for capital gains.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: